1. Home
  2. ELVR vs STXS Comparison

ELVR vs STXS Comparison

Compare ELVR & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVR
  • STXS
  • Stock Information
  • Founded
  • ELVR N/A
  • STXS 1990
  • Country
  • ELVR Australia
  • STXS United States
  • Employees
  • ELVR N/A
  • STXS N/A
  • Industry
  • ELVR Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ELVR Industrials
  • STXS Health Care
  • Exchange
  • ELVR Nasdaq
  • STXS Nasdaq
  • Market Cap
  • ELVR 254.1M
  • STXS 254.1M
  • IPO Year
  • ELVR N/A
  • STXS 2004
  • Fundamental
  • Price
  • ELVR $24.93
  • STXS $3.26
  • Analyst Decision
  • ELVR
  • STXS
  • Analyst Count
  • ELVR 0
  • STXS 0
  • Target Price
  • ELVR N/A
  • STXS N/A
  • AVG Volume (30 Days)
  • ELVR N/A
  • STXS 464.5K
  • Earning Date
  • ELVR N/A
  • STXS 11-10-2025
  • Dividend Yield
  • ELVR N/A
  • STXS N/A
  • EPS Growth
  • ELVR N/A
  • STXS N/A
  • EPS
  • ELVR N/A
  • STXS N/A
  • Revenue
  • ELVR N/A
  • STXS $31,806,000.00
  • Revenue This Year
  • ELVR N/A
  • STXS $30.92
  • Revenue Next Year
  • ELVR N/A
  • STXS $43.27
  • P/E Ratio
  • ELVR N/A
  • STXS N/A
  • Revenue Growth
  • ELVR N/A
  • STXS 33.94
  • 52 Week Low
  • ELVR N/A
  • STXS $1.54
  • 52 Week High
  • ELVR N/A
  • STXS $3.37
  • Technical
  • Relative Strength Index (RSI)
  • ELVR N/A
  • STXS 72.36
  • Support Level
  • ELVR N/A
  • STXS $2.97
  • Resistance Level
  • ELVR N/A
  • STXS $3.21
  • Average True Range (ATR)
  • ELVR 0.00
  • STXS 0.14
  • MACD
  • ELVR 0.00
  • STXS 0.03
  • Stochastic Oscillator
  • ELVR 0.00
  • STXS 87.82

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: